PX
52
2
SLG
31
3
NWSA
88
10
PYPL
31
6
AVB
50
-2
MMM
49
2
AIV
41
-3
PSA
46
-2
MCK
63
-3
HPQ
59
3
MCHP
51
6
CSX
43
2
KMI
53
2
HBI
31
-6
MS
62
7
GM
29
2
STI
36
3
WU
20
8
KR
55
-2
ICE
73
-2
PX
52
2
SLG
31
3
NWSA
88
10
PYPL
31
6
AVB
50
-2
MMM
49
2
AIV
41
-3
PSA
46
-2
MCK
63
-3
HPQ
59
3
MCHP
51
6
CSX
43
2
KMI
53
2
HBI
31
-6
MS
62
7
GM
29
2
STI
36
3
WU
20
8
KR
55
-2
ICE
73
-2
Financhill
Back

Duolingo Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
100

DUOL
Duolingo

Last Price:
$441.06
Seasonality Move:
15.16%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$105.33
Seasonality Move:
1.75%
Buy
100
Duolingo (DUOL) is a Buy

Is Duolingo a Buy, Sell or Hold?

  • The current Duolingo [DUOL] share price is $432.69. The Score for DUOL is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
  • DUOL is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DUOL Stock Price Chart

What is Duolingo's stock price today?

  • The Duolingo share price today is $432.69
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DUOL is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

DUOL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 21.45 Buy
Relative Strength Index (14 RSI): 74.9 Buy
Chaikin Money Flow: 400688 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (327.06 - 395.64) Buy
Bollinger Bands (100): (291.11 - 363.17) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

DUOL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 402.67 Buy
20-day SMA: 371.22 Buy
50-day SMA: 352.14 Buy
200-day SMA: 263.01 Buy
8-day EMA: 404.14 Buy
20-day EMA: 379.66 Buy
50-day EMA: 353.95 Buy
200-day EMA: 284.38 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

Duolingo Earnings Growth & DUOL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.34 per share, and an increase next year of $1.82 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Duolingo Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):